2BBBullish & Bearish
Aprea Therapeutics, Inc. (APRE) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 21 out of 100.
Aprea Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 20 | Weak |
| Risk | 48 | Moderate |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -0.2066 | — | $209,100.00 |
| 2026-08-10 | — | -0.2397 | — | $172,043.00 |
| 2026-05-12 | — | -0.3213 | — | $0.00 |
| 2026-03-23 | — | -0.3978 | — | $0.00 |